GRAFT FAILURE
Clinical trials for GRAFT FAILURE explained in plain language.
Never miss a new study
Get alerted when new GRAFT FAILURE trials appear
Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a once-daily pill prevent heart transplant rejection better than the standard twice-daily regimen?
Disease control CompletedThis study tested whether a once-daily anti-rejection medication (Envarsus) works as well as the standard twice-daily drug (Prograf) in heart transplant patients. Researchers looked at rates of organ rejection and graft failure, and whether taking the drug once a day helps patien…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
One-Dose drug may clear path to second kidney transplant
Disease control CompletedThis study tested whether a single dose of tocilizumab, given right before or after removing a failed kidney transplant, is safe and can reduce harmful immune reactions that make a second transplant difficult. 18 adults who needed their failed kidney removed and hoped for another…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New Blood-Cleansing method boosts transplant success for High-Risk patients
Disease control CompletedThis study looked at 50 patients who needed a stem cell transplant but had antibodies that could attack the donor cells. Before transplant, they received a blood purification treatment called protein A immunoadsorption to remove those antibodies. The goal was to see if this appro…
Matched conditions: GRAFT FAILURE
Sponsor: Ting YANG • Aim: Disease control
Last updated May 22, 2026 13:54 UTC